[Problems and prospects for clinical heparin use].
The paper contains new data on the pharmacodynamics of heparin and its interaction with the Xa factor, antithrombin III and thrombin. A critical assessment of the clinical efficacy of different types of heparin treatment of thromboembolisms is given, including thromboembolism of the pulmonary artery.
D000042:Absorption; D001792:Blood Platelets / Q000187:drug effects; D004087:Dihydroergotamine / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D013923:Thromboembolism / Q000188:drug therapy
D004087:Dihydroergotamine; D006493:Heparin
Problemy i perspektivy klinicheskogo primeneniia geparina.